lobbying_activities: 3389435

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3389435	28f2fd1c-540d-4fe9-8503-920e41a8cd08	Q2	BLUECROSS BLUESHIELD OF TENNESSEE	6440	BLUECROSS BLUESHIELD OF TENNESSEE	2025	second_quarter	PHA	Pharmacy Benefit Managers; Prescription Drug Cost; Delinking of Pharmacy H.R. 3839 - To amend the Federal Food, Drug, and Cosmetic Act to provide for increased transparency in generic drug applications S. 150- Affordable Prescriptions for Patients Act To amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes.	HOUSE OF REPRESENTATIVES,SENATE		140000	0	0	2025-07-17T15:17:15-04:00